Orbimed Advisors LLC Has $176.14 Million Position in Anthem, Inc. (ANTM)

Orbimed Advisors LLC increased its position in Anthem, Inc. (NYSE:ANTM) by 0.8% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 927,618 shares of the company’s stock after purchasing an additional 7,000 shares during the period. Anthem makes up approximately 1.7% of Orbimed Advisors LLC’s holdings, making the stock its 16th biggest position. Orbimed Advisors LLC owned 0.36% of Anthem worth $176,136,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently made changes to their positions in ANTM. Pioneer Investment Management Inc. bought a new position in Anthem in the 2nd quarter worth about $5,132,000. Global X Management Co. LLC raised its position in Anthem by 36.3% in the 2nd quarter. Global X Management Co. LLC now owns 6,085 shares of the company’s stock worth $1,145,000 after buying an additional 1,619 shares during the last quarter. Trexquant Investment LP purchased a new position in Anthem in the 2nd quarter worth about $245,000. First Trust Advisors LP raised its position in Anthem by 4.8% in the 2nd quarter. First Trust Advisors LP now owns 238,540 shares of the company’s stock worth $44,877,000 after buying an additional 10,864 shares during the last quarter. Finally, Teacher Retirement System of Texas raised its position in Anthem by 3.8% in the 2nd quarter. Teacher Retirement System of Texas now owns 88,923 shares of the company’s stock worth $16,729,000 after buying an additional 3,235 shares during the last quarter. Institutional investors own 87.26% of the company’s stock.

In related news, SVP Ronald W. Penczek sold 978 shares of the stock in a transaction that occurred on Tuesday, November 7th. The shares were sold at an average price of $217.42, for a total value of $212,636.76. Following the completion of the sale, the senior vice president now directly owns 1,222 shares of the company’s stock, valued at approximately $265,687.24. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Chairman Joseph Swedish sold 21,125 shares of the stock in a transaction that occurred on Friday, December 1st. The stock was sold at an average price of $231.43, for a total transaction of $4,888,958.75. Following the completion of the sale, the chairman now directly owns 87,668 shares of the company’s stock, valued at $20,289,005.24. The disclosure for this sale can be found here. Insiders sold a total of 65,955 shares of company stock valued at $13,907,287 over the last three months. 0.36% of the stock is currently owned by insiders.

Shares of Anthem, Inc. (NYSE ANTM) opened at $224.85 on Friday. Anthem, Inc. has a 52-week low of $140.50 and a 52-week high of $236.39. The company has a market cap of $57,732.49, a PE ratio of 18.05, a PEG ratio of 1.76 and a beta of 0.79. The company has a debt-to-equity ratio of 0.53, a quick ratio of 1.51 and a current ratio of 1.51.

Anthem (NYSE:ANTM) last released its quarterly earnings results on Wednesday, October 25th. The company reported $2.65 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $2.40 by $0.25. Anthem had a net margin of 3.35% and a return on equity of 12.97%. The firm had revenue of $22.10 billion during the quarter, compared to analyst estimates of $22.10 billion. During the same quarter in the prior year, the firm earned $2.45 EPS. The business’s revenue for the quarter was up 4.6% compared to the same quarter last year. sell-side analysts expect that Anthem, Inc. will post 11.97 earnings per share for the current fiscal year.

Anthem declared that its board has authorized a stock buyback program on Thursday, December 7th that allows the company to repurchase $5.00 billion in shares. This repurchase authorization allows the company to repurchase shares of its stock through open market purchases. Stock repurchase programs are often a sign that the company’s board of directors believes its stock is undervalued.

The company also recently announced a quarterly dividend, which will be paid on Thursday, December 21st. Investors of record on Tuesday, December 5th will be issued a $0.70 dividend. This represents a $2.80 annualized dividend and a yield of 1.25%. The ex-dividend date of this dividend is Monday, December 4th. Anthem’s dividend payout ratio is 25.32%.

A number of brokerages have weighed in on ANTM. B. Riley reissued a “buy” rating on shares of Anthem in a research report on Wednesday. Bank of America boosted their target price on Anthem from $249.00 to $254.00 and gave the stock a “buy” rating in a research report on Friday, November 17th. Leerink Swann reissued an “outperform” rating on shares of Anthem in a research report on Tuesday, November 7th. Credit Suisse Group began coverage on Anthem in a research report on Thursday, November 2nd. They issued an “outperform” rating and a $234.00 target price for the company. Finally, BidaskClub raised Anthem from a “hold” rating to a “buy” rating in a research report on Thursday, October 26th. Eight equities research analysts have rated the stock with a hold rating and eleven have issued a buy rating to the stock. The stock has a consensus rating of “Buy” and a consensus price target of $201.07.

TRADEMARK VIOLATION WARNING: “Orbimed Advisors LLC Has $176.14 Million Position in Anthem, Inc. (ANTM)” was reported by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are reading this article on another domain, it was stolen and reposted in violation of United States and international trademark & copyright laws. The correct version of this article can be read at https://www.dispatchtribunal.com/2017/12/10/orbimed-advisors-llc-has-176-14-million-position-in-anthem-inc-antm.html.

Anthem Profile

Anthem, Inc is a health benefits company. The Company operates through three segments: Commercial and Specialty Business, Government Business and Other. It offers a spectrum of network-based managed care plans to large and small employer, individual, Medicaid and Medicare markets. Its managed care plans include preferred provider organizations; health maintenance organizations; point-of-service plans; indemnity plans and other hybrid plans, including consumer-driven health plans; and hospital only and limited benefit products.

Institutional Ownership by Quarter for Anthem (NYSE:ANTM)

Receive News & Ratings for Anthem Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anthem Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply